Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
And sequence determines outcome
Retatrutide is an investigational drug that is not approved by the FDA or any regulatory body for the treatment of obesity, diabetes, or body recomposition outside of clinical trials
It's FDA-approved for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
PlexusDx supports whatever decision you and your medical team reach and can help you resume personalized therapy safely whenever that window opens
However, it is essential to evaluate these mechanisms in the context of pharmacological feasibility
US$ 26.15
US$ 21.86
US$ 22.93
US$ 27.52
US$ 26.97
